Skip to content
Screener

Apogee Therapeutics, Inc. APGE D&A

D&A at other companies

Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$17K-87.3%

Segments

By segment

See full
Reportable Segment Aggregation Before Other Operating$408K+97.1%

Other financials

Income statement

See full
Operating income-$82.8M-31.2%
Net income-$74.1M-33.9%
EPS (diluted)-$1.06-11.6%

Balance sheet

See full
Cash & equivalents$451.8M+323%
Total debt$8.0M-31.9%
Total assets$1.3B+81.1%

Cash flow

See full
Operating cash flow-$55.6M-14.6%
CapEx$62.0K—
Free cash flow-$62.8M+7.3%

Valuation

See full
Market cap$10.15B+379%
Enterprise value$9.71B+384%

Returns & leverage

See full
Current ratio32.6×+16.8×

FAQ

What does D&A mean?
Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.